SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Stålenheim Gunnemar)
 

Search: WFRF:(Stålenheim Gunnemar) > PI3-Kinase Regulate...

PI3-Kinase Regulates Eosinophil and Neutrophil Degranulation in Patients with Allergic Rhinitis and Allergic Asthma Irrespective of Allergen Challenge Model

Kämpe, Mary (author)
Uppsala universitet,Lungmedicin och allergologi,Asthma Research Centre
Lampinen, Maria (author)
Uppsala universitet,Institutionen för medicinska vetenskaper,Gastroenterology Research Group, Asthma Research Centre
Stolt, Ingrid (author)
Uppsala universitet,Institutionen för medicinska vetenskaper,Gastroenterology Research Group, Asthma Research Centre
show more...
Janson, Christer (author)
Uppsala universitet,Lungmedicin och allergologi,Asthma Research Centre
Stålenheim, Gunnemar (author)
Uppsala universitet,Lungmedicin och allergologi,Asthma Research Centre
Carlson, Marie (author)
Uppsala universitet,Institutionen för medicinska vetenskaper,Gastroenterology Research Group, Asthma Research Centre
show less...
 (creator_code:org_t)
2011-03-08
2012
English.
In: Inflammation. - : Springer Science and Business Media LLC. - 0360-3997 .- 1573-2576. ; 35:1, s. 230-239
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The PI3K pathway plays a major role in many vital cell processes. Our primary aim was to investigate signalling through PI3K for in vitro degranulation from allergen-primed eosinophils and neutrophils in allergic rhinitis and allergic asthma after seasonal and experimental allergen challenge. Nine patients with allergic rhinitis, eight with allergic asthma and four controls were studied during birch pollen season and after nasal and bronchial allergen challenge. Primed blood eosinophils and neutrophils were stimulated for in vitro degranulation with C3b-coated Sephadex particles, after prior incubation with Wortmannin, a PI3K inhibitor. The released amounts of eosinophil cationic protein (ECP), eosinophil peroxidase (EPO) and myeloperoxidase (MPO) were measured by radioimmunoassay. Wortmannin (10(-6) to 10(-9) M) inhibited ECP, EPO and MPO release in a dose-dependent manner in allergic rhinitis and allergic asthma in all three allergen challenge models. Inhibition of ECP release tended to be lower in the asthmatics in all allergen challenge models, statistically significant compared to the controls during season for 10(-8) M Wortmannin (p = 0.01). A clear propensity towards less inhibition in the rhinitic patients was seen after nasal and bronchial challenge compared to seasonal exposure, significant for ECP (10(-8) M Wortmannin; p = 0.034 and 0.002, respectively). Signalling through PI3K is clearly involved in ECP, EPO and MPO release in allergic rhinitis and allergic asthma irrespective of allergen challenge model. Allergic asthma demonstrated less inhibition of ECP release via PI3K during pollen season, indicating that other pathways play a greater role in eosinophil degranulation in allergic asthma than allergic rhinitis.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Lungmedicin och allergi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Respiratory Medicine and Allergy (hsv//eng)

Keyword

Eosinophil inflammation
allergic rhinitis
allergic asthma
eosinophil degranulation
PI3K
ECP
Lung diseases
Lungsjukdomar
Lung Medicine
Lungmedicin

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Find more in SwePub

By the author/editor
Kämpe, Mary
Lampinen, Maria
Stolt, Ingrid
Janson, Christer
Stålenheim, Gunn ...
Carlson, Marie
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Clinical Medicin ...
and Respiratory Medi ...
Articles in the publication
Inflammation
By the university
Uppsala University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view